Unibest
← Back to patent-cliff list

CAS 138401-24-8

4'-((2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl)-[1,1'-biphenyl]-2-carbonitrile

Codes: IRBE-005

Application context (from source-drug indications)

HypertensionAtorvastatin Calcium Hydrate/IrbesartanHyperlipidaemiaAtorvastatin Calcium Hydrate/IrbesartanHypertensionIrbesartan/TrichlormethiazideOesophageal diseaseIrbesartanHypertensionIrbesartanDiabetic nephropathyIrbesartanHypercholesterolaemiaIrbesartanAlbuminuriaIrbesartanType 2 diabetesIrbesartan

Source drugs (routes using this intermediate)

DrugTierExpiry
Atorvastatin Calcium Hydrate/IrbesartanTier C — Watch / trade-
Irbesartan/TrichlormethiazideTier C — Watch / trade-
IrbesartanTier B — Position early-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

IrbesartanOptimised routesteps: 4total yield: 1.05 g
IrbesartanOptimised routesteps: 5total yield: /

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.